8.99
price down icon2.18%   -0.20
after-market 시간 외 거래: 8.99
loading

Upstream Bio Inc 주식(UPB)의 최신 뉴스

pulisher
May 03, 2026

Jennison Associates LLC Makes New Investment in Upstream Bio, Inc. $UPB - MarketBeat

May 03, 2026
pulisher
May 01, 2026

UPB Stock Price, Quote & Chart | UPSTREAM BIO INC (NASDAQ:UPB) - ChartMill

May 01, 2026
pulisher
Apr 29, 2026

Upstream Bio down despite mid-stage trial win for asthma drug - MSN

Apr 29, 2026
pulisher
Apr 29, 2026

Upstream Bio (UPB) price target decreased by 10.31% to 44.37 - MSN

Apr 29, 2026
pulisher
Apr 28, 2026

Upstream Bio lead drug pivotal trial plan follows strong phase 2 data - MSN

Apr 28, 2026
pulisher
Apr 28, 2026

UPB Forecast, Price Target & Analyst Ratings | UPSTREAM BIO INC (NASDAQ:UPB) - ChartMill

Apr 28, 2026
pulisher
Apr 24, 2026

Segment Overview and Major Growth Areas in the Upstream Bioprocessing Market - openPR.com

Apr 24, 2026
pulisher
Apr 23, 2026

Chronic Obstructive Pulmonary Disease Clinical Trial Landscape Expands: Over 65 Companies Advancing Next-Generation Therapies | DelveInsight - GlobeNewswire Inc.

Apr 23, 2026
pulisher
Apr 22, 2026

Upstream Bio, Inc. (NASDAQ:UPB) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Apr 22, 2026
pulisher
Apr 20, 2026

Upstream Bio (UPB) Stock Bonus Issue (Bearish Sentiment) 2026-04-20Bullish Pattern - Newser

Apr 20, 2026
pulisher
Apr 18, 2026

Upstream Bio (UPB) Stock Ask Wall (Trend Weakens) 2026-04-18Upside Potential - Cổng thông tin điện tử tỉnh Lào Cai

Apr 18, 2026
pulisher
Apr 18, 2026

Upstream Bio to Present New Data from Phase 2 VIBRANT Trial of Verekitug at the ATS 2026 International Conference - Sahm

Apr 18, 2026
pulisher
Apr 17, 2026

Upstream Bio to present verekitug data at medical conference By Investing.com - Investing.com Australia

Apr 17, 2026
pulisher
Apr 17, 2026

Upstream Bio to present verekitug data at medical conference - Investing.com

Apr 17, 2026
pulisher
Apr 13, 2026

Can Upstream Bio (UPB) Stock Beat Estimates | Price at $10.24, Down 2.38%Hot Momentum - Cổng thông tin điện tử tỉnh Lào Cai

Apr 13, 2026
pulisher
Apr 13, 2026

Bull Bear: Is Upstream Bio Inc a cyclical or defensive stock2026 Intraday Action & Low Drawdown Trading Strategies - baoquankhu1.vn

Apr 13, 2026
pulisher
Apr 11, 2026

UPB Options Volatility — NASDAQ:UPB - TradingView — Track All Markets

Apr 11, 2026
pulisher
Apr 11, 2026

UPB Options Chain — NASDAQ:UPB - TradingView

Apr 11, 2026
pulisher
Apr 07, 2026

Validating the IL-13/TSLP Axis: Upstream Bio’s Verekitug Positioned for Differentiated Asthma Efficacy and Favorable Risk–Reward - TipRanks

Apr 07, 2026
pulisher
Apr 06, 2026

Earnings Update: Is Upstream Bio Inc still a buy after recent gains2026 Rallies & Reliable Entry Point Trade Alerts - baoquankhu1.vn

Apr 06, 2026
pulisher
Apr 06, 2026

Analysts Offer Insights on Healthcare Companies: Upstream Bio, Inc. (UPB) and Pfizer (PFE) - The Globe and Mail

Apr 06, 2026
pulisher
Apr 02, 2026

Truist cuts Upstream Bio stock price target on trial timeline By Investing.com - Investing.com Canada

Apr 02, 2026
pulisher
Apr 02, 2026

Market Recap: Is Upstream Bio Inc forming a bullish divergence2026 Volume & Daily Chart Pattern Signals - baoquankhu1.vn

Apr 02, 2026
pulisher
Apr 02, 2026

Piper Sandler Maintains UpStream Bio(UPB.US) With Buy Rating, Maintains Target Price $75 - Moomoo

Apr 02, 2026
pulisher
Apr 01, 2026

Upstream Bio, Inc. (UPB) Stock Price Prediction for 2026, 2030-2040 - Traders Union

Apr 01, 2026
pulisher
Mar 31, 2026

Retail Surge: Does Upstream Bio Inc have a sustainable dividendTrade Signal Summary & Verified Trade Idea Suggestions - baoquankhu1.vn

Mar 31, 2026
pulisher
Mar 31, 2026

UpStream Bio | 10-K: FY2025 Annual Report - Moomoo

Mar 31, 2026
pulisher
Mar 28, 2026

Upstream Bio, Inc. (NASDAQ:UPB) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Mar 28, 2026
pulisher
Mar 28, 2026

Upstream Bio (NASDAQ:UPB) Rating Lowered to Sell at Wall Street Zen - MarketBeat

Mar 28, 2026
pulisher
Mar 27, 2026

VALIANT Asthma Trial Update: What Upstream Bio’s Phase 2 Milestone Means for Investors - TipRanks

Mar 27, 2026
pulisher
Mar 27, 2026

Upstream Bio (NASDAQ:UPB) Downgraded by Evercore to In-Line - MarketBeat

Mar 27, 2026
pulisher
Mar 27, 2026

A Quick Look at Today's Ratings for UpStream Bio(UPB.US), With a Forecast Between $15 to $42 - moomoo.com

Mar 27, 2026
$28.28
price down icon 1.87%
$50.20
price down icon 1.03%
$104.80
price down icon 23.55%
$93.02
price down icon 2.35%
$142.51
price down icon 5.67%
ONC ONC
$317.00
price up icon 1.17%
자본화:     |  볼륨(24시간):